• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker CEO: Rumors swirl over MacMillan’s departure

Stryker CEO: Rumors swirl over MacMillan’s departure

February 28, 2012 By MassDevice staff

Stephen MacMillan

Former Stryker (NYSE:SYK) CEO Stephen MacMillan’s departure from the company may have come as the result of an extramarital affair with a former company employee, according to a report in the Wall Street Journal.

The paper reported that MacMillan resigned from the Kalamazoo, Mich.-based medical device company on February 8th after losing the confidence of some "key members" of the company’s board, who had becomed concerned about alleged relationship the 48-year-old executive had with an ex-employee.

MacMillan abruptly resigned from the world’s largest orthopedics device maker this month citing family reasons. Stryker revealed to stock analysts shortly thereafter that he was romantically involved with a former employee, the Journal reported, citing anonymous sources that have not yet been independently verified.

MacMillan’s decision left many scratching their heads when the announcement was made. Stryker officials insisted that his resignation had nothing to do with his performance in the corner office, but was related only to personal reasons that began late last year.

MacMillan’s wife, Amy, filed for divorce in September, 2011, according to the newspaper. They’ve been married in 1987.

In addition to ceding the corner office at Stryker, MacMillan stepped down from Texas Instruments’ board of directors this month and there is no word yet on whether he will retain his upcoming chairman role at AdvaMed, the medical device’s industry council.

Stryker agreed to a hefty severance package for the outgoing executive, including $5.5 million in cash at the end of this month and an option to purchase nearly $65 million worth of company stock, among other perks.

Stryker CFO Curt Hartman, will serve as the interim CEO while the company looks for a permanent successor to MacMillan, who had the job for 7 years and signs off officially on Wednesday. William Parfet, the board’s lead independent director, was named the non-executive chairman to replace MacMillan on the board.

Stryker has declined all comment on the matter, telling MassDevice that the company "won’t be taking any interviews on this topic and have no further comments."

MacMillan’s next move may be to a post at a private-equity firm, according to the Journal.

Filed Under: News Well Tagged With: Personnel Moves, Stryker

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy